- April 7, 2014Canadian Antitrust Class Actions — A Business Opportunity
- April 4,2014Finding the Line Separating Infringement and Exempt Uses: Enforcing Biotechnology Patents in View of 35 U.S.C. § 271(e)(1)
- April 4, 2014The Eight Corners Rule: Uncertainty On Duty To Defend
- March 19, 2014Patent Owners Beware, Your Patent has a 15 Percent Chance (Or Less) of Surviving the PTAB
- Maintaining the Attorney-Client and Work-Product Privileges in an Internal Investigation
- March 18, 2014Inter Partes Review: Is It Working to Make the Patent System Better?
- Let's Chat About the Legal Risks of Instant Messaging
- March 13, 2014Staying Alive Redux
- March 6, 2014Central District of California Holds That Criminal Amnesty Recipients not Entitled to ACPERA Benefits in Parallel Civil Action Where Cooperation in Civil Action Untimely
- Harnessing Big Data to Turn Consumer Social Media into Trade Secrets by Tom Mahlum
- IP: The Eastern District of Texas Issues a Reality Check in 2013
- U.S. Patent Trial and Appeal Board Decisions: Secondary Considerations of Non-Obviousness—Worthy Argument or Lost Cause?
- March 2014Leadership Models in Health Care A Case for Servant Leadership
- The Continuing Saga of Mayo v. Prometheus
- Use Outside Counsel to Control Data Breach Loss
- IP: Maybe We Should Let the Dust Settle or the Swirling Vortex of Patent Reform
- In Practice: Copyright Infringement and Reality TV
- February 14, 2014Twombly Affects All Elements Of Antitrust Claims
- February 3, 2014What About My Fees?
- IP: Do the New Patent Office Trials Really Make Patent Litigation Cheaper?
- January 29, 20149th Circuit Joins Others With Arbitration Appealability Ruling
- January 25, 2014Beware Your Telephone: Telephone Consumer Protection Act and Call Recording Class Actions Rise as Advertising Injury Insurance Coverage Declines
- Winter 2013Noven Pharms., Inc. v. Watson Labs., Inc.
- IP: Is Inter Partes Review an Improvement Over Inter Partes Reexam?
- Winter 2013Auxilium Pharms., Inc. v. FCB I LLC
- Winter 2013AstraZeneca AB v. Apotex Corp.
- Winter 2013ViiV Healthcare UK Ltd. v. Lupin Ltd.
- Winter 2013Cephalon, Inc. v. Sun Pharms., Ltd.
- Winter 2013AstraZeneca LP v. Breath Ltd.
- Winter 2013Cadence Pharms., Inc. v. Exela Pharms. Sciences, LLC
- Winter 2013The Medicines Co. v. Mylan, Inc.
- Winter 2013Galderma Labs., L.P. v. Tolmar, Inc.
- Winter 2013Prometheus Labs. Inc. v. Roxane Labs., Inc.
- Winter 2013Fresenius USA, Inc. v. Baxter International, Inc.
- Winter 2013Insite Vision Inc. v. Sandoz Inc.
- Winter 2013AstraZeneca AB v. Hanmi USA, Inc.
- Winter 2013Auxilium Pharms., Inc. v. Upsher-Smith Laboratories, Inc.
- Winter 2013Novartis Pharma. Corp. v. Wockhardt USA LLC
- January 21, 2014High Bar for 'Natural' Class, Despite FDA Ambiguity
- January 16, 2014Why More Rule Amendments?
- Winter 2013ANDA Litigation Settlements
- Winter 2013New ANDA Cases
- Winter 2013ANDA Approvals
- Winter 2013
- IP: 3D Printing Patent Litigation Now: The Shape of Things to Come?
- Court Split Over Contra Proferentem Doctrine Widens
- Stryker® Orthopedics Recalls its Rejuvenate® and ABG™ II Modular-Neck Hip Stems
- For My Appellate Christmas Stocking
- December 19, 2013Day of Reckoning for Securities Class Actions
- IP: Thinking Ahead about 3D Printing
